Pharma Medica Research
Pharma Medica Research, a leading name in the pharmaceutical research industry, is headquartered in California and operates extensively across North America. Founded in 2006, the company has established itself as a trusted partner in clinical research, specialising in Phase I-IV clinical trials, bioanalytical services, and regulatory consulting. With a commitment to innovation and quality, Pharma Medica Research offers unique solutions that streamline the drug development process, ensuring compliance and efficiency. The company has achieved significant milestones, including numerous successful trial completions and partnerships with major pharmaceutical firms, solidifying its position as a key player in the market. Recognised for its expertise and dedication to advancing healthcare, Pharma Medica Research continues to contribute to the evolution of medical science, making it a vital resource for clients seeking reliable research services.
DitchCarbon Score
How does Pharma Medica Research's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma Medica Research's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma Medica Research's reported carbon emissions
Pharma Medica Research, headquartered in CA, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting its emissions. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and reducing their carbon footprints, often setting ambitious targets aligned with global climate initiatives. As such, it is essential for Pharma Medica Research to establish clear emissions reporting and reduction strategies to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Medica Research is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
